Fatty Acid-Binding Protein 4 (FABP4): Pathophysiological Insights and Potent Clinical Biomarker of Metabolic and Cardiovascular Diseases.
about
PPARs Link Early Life Nutritional Insults to Later Programmed Hypertension and Metabolic SyndromeSex-Specific Muscular Maturation Responses Following Prenatal Exposure to Methylation-Related Micronutrients in PigsSerum FABP5 concentration is a potential biomarker for residual risk of atherosclerosis in relation to cholesterol efflux from macrophagesSerum from pregnant women with gestational diabetes mellitus increases the expression of FABP4 mRNA in primary subcutaneous human pre-adipocytesAlteration of Gene Expression Profile in Kidney of Spontaneously Hypertensive Rats Treated with Protein Hydrolysate of Blue Mussel (Mytilus edulis) by DNA Microarray AnalysisExpression of FABP4, adipsin and adiponectin in Paneth cells is modulated by gut LactobacillusEffects and Molecular Mechanism of GST-Irisin on Lipolysis and Autocrine Function in 3T3-L1 AdipocytesPossible Increase in Serum FABP4 Level Despite Adiposity Reduction by Canagliflozin, an SGLT2 Inhibitor.Systemic adaptation of lipid metabolism in response to low- and high-fat diet in Nile tilapia (Oreochromis niloticus)Transcriptome and Metabolome Analyses in Exogenous FABP4- and FABP5-Treated Adipose-Derived Stem CellsReduction of serum FABP4 level by sitagliptin, a DPP-4 inhibitor, in patients with type 2 diabetes mellitus.Gene Expression and Correlation of Pten and Fabp4 in Liver, Muscle, and Adipose Tissues of Type 2 Diabetes Rats.Reduction of circulating FABP4 level by treatment with omega-3 fatty acid ethyl esters.Gender difference in plasma fatty-acid-binding protein 4 levels in patients with chronic obstructive pulmonary diseaseNovel flow cytometric approach for the detection of adipocyte subpopulations during adipogenesis.Associations of A-FABP with Anthropometric and Metabolic Indices and Inflammatory Cytokines in Obese Patients with Newly Diagnosed Type 2 Diabetes.High Serum Adipocyte Fatty Acid Binding Protein Is Associated with Metabolic Syndrome in Patients with Type 2 Diabetes.Serum Fatty Acid-Binding Protein 4 is Increased in Patients with Psoriasis.Level of FABP3, FABP4, Nt-proBNP and Total Cardiovascular Risk in the Population of Central Kazakhstan.Anti-obesity effect of Solidago virgaurea var. gigantea extract through regulation of adipogenesis and lipogenesis pathways in high-fat diet-induced obese mice (C57BL/6N).Interaction between prenatal pesticide exposure and a common polymorphism in the PON1 gene on DNA methylation in genes associated with cardio-metabolic disease risk-an exploratory studyAnti-Obesity Effect of the Above-Ground Part of Valeriana dageletiana Nakai ex F. Maek Extract in High-Fat Diet-Induced Obese C57BL/6N Mice.Serum adipocyte-fatty acid binding protein (FABP4) levels in women from Mexico exposed to polycyclic aromatic hydrocarbons (PAHs).Adipocyte Fatty-Acid Binding Protein is Overexpressed in Cirrhosis and Correlates with Clinical Outcomes.Milk's Role as an Epigenetic Regulator in Health and DiseaseHypertension, C Reactive Protein and Metabolic Profile: What is the Scenario in Patients Undergoing Arteriography?Ectopic Fatty Acid-Binding Protein 4 Expression in the Vascular Endothelium is Involved in Neointima Formation After Vascular Injury.Inflammation, Atherosclerosis and Coronary Artery Disease.Fatty acid-binding protein 4 regulates fatty infiltration after rotator cuff tear by hypoxia-inducible factor 1 in mice.CD38 deficiency suppresses adipogenesis and lipogenesis in adipose tissues through activating Sirt1/PPARγ signaling pathway.Elevated serum tartrate-resistant acid phosphatase isoform 5a levels in metabolic syndrome.Serum Concentrations of New Predictive Cardiovascular Disease Biomarkers in Mexican Women Exposed to Lead.Bariatric Surgery Is Accompanied by Changes in Extracellular Vesicle-Associated and Plasma Fatty Acid Binding Protein 4.A vicious loop of fatty acid-binding protein 4 and DNA methyltransferase 1 promotes acute myeloid leukemia and acts as a therapeutic target.Differentially expressed alternatively spliced genes in skeletal muscle from cancer patients with cachexia.Pre- and post-prandial expression of genes involved in lipid metabolism at the end of the overfeeding period of mule ducks.Urinary L-FABP as a marker of vesicoureteral reflux in children: could it also have a protective effect on the kidney?Quantitative Proteomic Analysis of Hepatic Tissue of T2DM Rhesus Macaque.Spatial Tissue Proteomics Quantifies Inter- and Intratumor Heterogeneity in Hepatocellular Carcinoma (HCC).Fatty acid binding protein 4 enhances prostate cancer progression by upregulating matrix metalloproteinases and stromal cell cytokine production.
P2860
Q26771825-9B29CA07-3911-4B1B-98DD-BACF5E7F5B03Q30313528-524C8E92-4193-4DA9-B8AA-695B8102271CQ33669547-2CCFAFEE-3BD9-43B9-A869-CA73FDB125E0Q33711860-9311CCC2-A4A6-4582-BC5A-E6D4E352495EQ35827412-715296A5-ED59-496A-A338-1C4D3A87FF9DQ35873800-67E93EF5-9E18-46F4-AB15-372B1508A680Q35901186-0C13CF35-CF73-4485-BFF8-0ED5F4B7906BQ36001903-B5BB3036-0EA7-43F3-BA4E-7CFB44E5FC2DQ36036441-87552703-8B9A-447A-B3DD-E6E78E47AA04Q36218431-7E5594B5-1D36-4EA2-8B56-034B0FD37194Q36307279-95865B0E-94F2-41FF-92E2-847A8F480A37Q36325637-B8AEBCE5-461B-4EE7-9BE3-A9643AEC63B2Q36454709-E2A7C9A2-497C-4811-BF07-F06DF6082FBCQ36628196-FE2EC8EF-7E10-4709-BD40-B0AD2FCB6714Q36731731-BAE60EC4-C186-4A2E-839D-7F275EEA6D14Q37368781-868E3A12-6C55-42D7-98FD-B3373B3207ABQ37497167-05DD5974-D895-4959-9CFA-56B7295B7146Q37575141-2CC5CEA3-4179-4C16-9557-EDA830BB7845Q37658760-29A7023A-5539-4E3A-AB8C-933D8233D2D8Q37693280-42857C6C-FC92-4EB7-AD7E-83C3E6BD87E5Q37739313-E7FFB8AD-AAD1-414C-8845-41A47E110349Q38696913-3BD74B2A-08EB-40B6-A7B0-619EFC55C318Q39233265-9D20B4DC-5C3C-4619-BD8C-481B36B7EA60Q41786318-06ED5BDE-410E-462D-93AC-29BF359140EFQ42226744-0A69E0B7-B415-4750-A861-4BE38DA9CC6DQ42366988-BB3C8EB6-17C2-42D4-A266-B0BCD0C488F1Q42373725-D93E79FF-C486-4486-8382-6A274CBDD881Q42400279-B7027512-5418-48F5-B14D-349AF4F63683Q42751172-EAEC6C62-9DB5-4B68-8D16-D7E53014B951Q42798222-6CC966E3-B10E-41DA-B192-AF94EE4AA14FQ47140169-74E118FC-8593-4F5E-99BB-9DC4956A1DF0Q47267706-54BD7A64-6497-4D62-A6E0-BC284EC2213BQ47642599-BFA30114-8323-42EF-93D1-EB4463F8FD55Q47674218-7012EEC8-DA8E-4BA0-8D9B-589F3B08B08CQ47688408-01D2EB60-F16C-46C6-B2E4-F8B81C55E249Q48001448-96F08E70-5606-457E-B4C4-F68473D06217Q48101168-6CAC4F8B-8D30-481B-8573-F3A3ED4A364BQ48102189-1590F071-13D4-4644-983E-2CABFEC1959BQ49832163-68BA710D-7B4A-4255-A1AF-BC734EC7F0D6Q50017129-106C1E17-69FE-4B5F-B4F0-0FF572CA9070
P2860
Fatty Acid-Binding Protein 4 (FABP4): Pathophysiological Insights and Potent Clinical Biomarker of Metabolic and Cardiovascular Diseases.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Fatty Acid-Binding Protein 4 ( ...... c and Cardiovascular Diseases.
@en
type
label
Fatty Acid-Binding Protein 4 ( ...... c and Cardiovascular Diseases.
@en
prefLabel
Fatty Acid-Binding Protein 4 ( ...... c and Cardiovascular Diseases.
@en
P2093
P2860
P921
P356
P1476
Fatty Acid-Binding Protein 4 ( ...... c and Cardiovascular Diseases.
@en
P2093
Kazuaki Shimamoto
Shigeyuki Saitoh
Tetsuji Miura
P2860
P356
10.4137/CMC.S17067
P433
P577
2014-01-01T00:00:00Z